Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Multicenter Evaluation of Intravenous Levosimendan Efficacy Versus Placebo in the Short Term Treatment of Decompensated Chronic Heart Failure: the REVIVE II Study.

NCT00048425 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00048425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00048425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Multicenter Evaluation of Intravenous Levosimendan Efficacy Versus Placebo in the Short Term Treatment of Decompensated Chronic Heart Failure: the REVIVE II Study.
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2002
Completion date
December 31, 2004
Enrollment
600
Sites
166

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, congestive